Back to News
Market Impact: 0.15
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Source: GlobeNewswire
Management & GovernanceHealthcare & Biotech
Entera added a former Gilead and Amgen executive with more than 35 years of experience advancing and commercializing therapies. The brief announcement provides no details on the executive’s role, specific therapies, or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
ENTX0.50
More News
- Cantor Fitzgerald reiterates Ideaya Biosciences stock rating
- Paramount's hard-fought takeover of Warner Bros. Discovery closes Tuesday. Here's how we got here
- CNN, CBS News now under one roof as Paramount-Warner Bros merger closes
- Paramount Closes Warner Merger in Historic Hollywood Deal
- Skydance will combine HBO Max and Paramount+ into a single streaming service
- Read the memo from Skydance's product chief after Paramount and WBD joined forces